Brenus Pharma raises $12.6M Series A (France, Jul 2026)

Brenus Pharma raises €11 million Series A extension to advance immunotherapy for hard-to-treat solid tumours - EU-Startups

Brenus Pharma is a Lyon-based clinical-stage biotech startup focused on preventing cancer recurrence through innovative immunotherapy solutions. The company is developing a platform that engages the immune system to target hard-to-treat solid tumors, utilizing a novel dendritic cell-engager modality to convert cold tumors into responsive ones. This funding will help advance their next drug candidate and complete their Phase I program.

Brenus Pharma raises €11 million Series A extension to advance immunotherapy for hard-to-treat solid tumours  EU-Startups